Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ·Healthcare·Biotechnology
$62.20
+2.29%
Mkt Cap $2.69B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (11 analysts)
$89.33
Range $68.00 – $100.00
Implied Upside
+43.6%
Consensus $89.33 vs current $62.20
NASDAQ·Healthcare·Biotechnology
$62.20
+2.29%
Mkt Cap $2.69B
Buy
3
Hold
0
Sell
0
Price Target (11 analysts)
$89.33
Range $68.00 – $100.00
+43.6%
Consensus $89.33 vs current $62.20